Nuvation Bio Ownership | Who Owns Nuvation Bio?
Nuvation Bio Ownership Summary
Nuvation Bio is owned by 8.20% institutional investors, 18.99% insiders, and 72.81% retail investors. Fmr is the largest institutional shareholder, holding 14.84% of NUVB shares.
NUVB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvation Bio | 8.20% | 18.99% | 72.81% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 50.57M | 14.84% | $187.11M |
| Decheng capital | 25.95M | 7.62% | $96.03M |
| Blackrock | 16.24M | 7.41% | $47.41M |
| Blackrock funding, inc. /de | 24.60M | 7.22% | $91.04M |
| Vanguard group | 15.45M | 4.54% | $57.18M |
| Laurion capital management lp | 9.71M | 2.85% | $35.91M |
| Omega fund management | 8.83M | 2.59% | $32.68M |
| State street | 6.09M | 1.79% | $22.53M |
| Geode capital management | 5.89M | 1.73% | $21.79M |
| Nuveen | 4.57M | 1.34% | $16.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Decheng capital | 25.95M | 16.75% | $96.03M |
| Omega fund management | 8.83M | 14.69% | $32.68M |
| Tanaka capital management | 685.11K | 4.56% | $2.54M |
| Edbi pte | 1.27M | 3.58% | $3.38M |
| Knoll capital management | 1.02M | 2.97% | $5.54M |
| Aisling capital management lp | 2.96M | 2.40% | $10.95M |
| Octagon capital advisors lp | 2.63M | 1.48% | $9.74M |
| Redmile group | 3.03M | 1.09% | $11.21M |
| Ghost tree capital | 1.15M | 1.05% | $3.36M |
| Palo alto investors lp | 1.02M | 0.70% | $3.78M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 16.24M | 0.00% | 3.71M |
| Nuveen | 4.57M | 0.00% | 3.08M |
| Jane street group | 2.32M | 0.00% | 2.32M |
| Armistice capital | 2.30M | 0.13% | 1.80M |
| Pale fire capital se | 1.44M | 0.59% | 1.35M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -19.21M |
| Octagon capital advisors lp | 2.63M | 1.48% | -5.06M |
| Bioimpact capital | - | - | -4.62M |
| Rosalind advisors | - | - | -2.45M |
| Omega fund management | 8.83M | 14.69% | -2.21M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jane street group | 2.32M | 0.00% | 2.32M | $8.59B |
| Ghost tree capital | 1.15M | 1.05% | 1.15M | $3.36M |
| Woodline partners lp | 955.41K | 0.02% | 955.41K | $3.54M |
| Tanaka capital management | 685.11K | 4.56% | 685.11K | $2.54M |
| Hrt financial lp | 631.15K | 0.01% | 631.15K | $2.33M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -28.00 |
| Lindbrook capital | -154.00 |
| Corecap advisors | -237.00 |
| Capital performance advisors llp | -281.00 |
| Covestor | -384.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 76 | -56.82% | 27,947,807 | -87.00% | 8 | 0.21% | 42 | -64.71% | 17 | -39.29% |
| Jun 30, 2025 | 184 | 14.29% | 224,710,788 | 8.38% | 65 | 1.76% | 122 | 64.86% | 30 | -42.31% |
| Mar 31, 2025 | 160 | - | 207,338,637 | 4.87% | 61 | 1.17% | 74 | -19.57% | 51 | 45.71% |
| Dec 31, 2024 | 148 | -5.13% | 179,374,596 | -4.45% | 65 | 1.39% | 83 | -3.49% | 35 | -2.78% |
| Sep 30, 2024 | 155 | 4.73% | 187,725,271 | 23.08% | 68 | 1.42% | 86 | -1.15% | 36 | -5.26% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 01, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $1.17M |
| Nov 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $80.00K |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $75.00K |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | $2.17M |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $140.07K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q2 | 11 | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | 1 |
NUVB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools